Emkay, Motilal Oswal and Edelweiss have retained buy ratings while Macquarie and JPMorgan have retained outperform and overweight rating, respectively.
Analysts at Emkay said HCL Technologies’ operating performance missed expectations largely due to a 8 per cent quarter on quarter decline in products and platform business on a constant currency basis. Emkay, while lowering earnings estimates by 0.8-3.3 per cent, said it has maintained a buy on attractive valuation and anticipated revenue acceleration.
Motilal Oswal expects HCL Technologies to emerge stronger on the back of an expected increase in enterprise demand for these services. “The stock is currently trading at around 22 times FY23 estimated EPS, which offers a margin of safety,” said Motilal Oswal.
Morgan Stanley and Macquarie have trimmed target price on HCL Technologies by 2 per cent and 3 per cent, respectively. Macquarie has lowered earnings estimates for FY22-FY24 by 2-6 per cent as weakness in products business led to HCL missing result expectations.